retatrutide drug trial Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide: A Promising Option for

The questions that remain unanswered include the actual prevalence of sexual side effects (we do not know if it affects 5 percent or 30 percent of women), whether certain doses are more likely to cause sexual dysfunction than others, whether compounded semaglutide formulations produce different sexual side effect profiles than brand-name versions, whether specific pharmacy sources or compounding pharmacies produce formulations with different tolerability profiles, and whether pre-treatment screening can identify women at higher risk for sexual dysfunction on GLP-1 agonists

Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR

It combines prebiotics, probiotics, postbiotics, digestive enzymes, and superfood blends to boost nutrient absorption and support the microbiome, gut barrier, and immune health

1 2 "Urinalysis"

Je huid weerspiegelt hoe je je voelt